The Way Forward for Decentralise Clinical Trials in Japan: As Decentralized clinical trials, brings participants the opportunity of participating in a clinical trial from the ease of their home or a local healthcare facility which is different to the traditional clinical trial site location far from the participant’s home. 3H, a Home-based clinical trial leader […]
Initiating the provision of analysis information on differences in drug effects for each genetic polymorphism for contributing to the advancement of drug development and improvement in treatment options and treatment satisfaction for patients. 3H Medi Solution Inc. (Toshima-ku, Tokyo; CEO: Hirotaka Takizawa) and Genequest Inc. (Minato-ku, Tokyo; CEO: Osamu Iwata) have jointly conducted an analysis […]
The world is transitioning into the information age in healthcare and modern digital health technologies have a lot to offer in optimising clinical trial conduct. The advent of wearable medical devices has enabled collection of multi-dimensional subject data. This has enabled de-centralisation of clinical trial conduct. 3H has been agile to adopt the latest information […]
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative Director, Hirotaka Takizawa; “3H”) announced that the companies developed and started providing “Fukusapo”, an adverse drug reaction (ADR) management supporting tool for patients as from today, aiming at the ADR management in patients receiving the […]
Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing many challenges in the Western world due to escalating costs and challenges in meeting the recruitment and retention of subjects, there is a trend in navigating clinical trial options in the Asian continent. Contract research […]
LOS ANGELES and TOKYO, October 27, 2021 — Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science […]
System integration between ePRO (electronic patient report outcome) and electronic medical record (EMR). Possibility to confirm data input from electronic medical record itself done on the cancer patient app. Improve the quality of medical care by utilizing ICT in line with the medical field. St. Marianna University School of Medicine (Kawasaki City, Kanagawa Prefecture, President: […]
Non-small cell lung cancer (NSCLC), which is a type of epithelial lung cancer is prevalent in Japan. The absolute number of newly reported cases and deaths in men and women have increased over the years. Building awareness about the trial is an important strategy for recruitment. It is important that not just patients with NSCLC […]
South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]
Medical care is undergoing rapid changes and the latest technology has provided solutions for the growing complex problems in aging care and other healthcare needs. With the pandemic taking a toll, it has added innovative care delivery methods for the nursing of patients from the comfort of homes moving beyond the traditional hospital beds where […]
© 2024 · Your Website. Theme by HB-Themes.